Dashboard
Manage Tickers

CRDF


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cardiff-oncology-q3-eps-017-beats-020-estimate-sales-120000k-beat-112500k-estimate
Cardiff Oncology Q3 EPS $(0.17) Beats $(0....
11/06/2025 21:37:35

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0....

a-glimpse-into-the-expert-outlook-on-cardiff-oncology-through-4-analysts
A Glimpse Into The Expert Outlook On Cardi...
08/06/2025 13:02:22

amd-to-rally-more-than-20-here-are-10-top-analyst-forecasts-for-wednesday
AMD To Rally More Than 20%? Here Are 10 To...
08/06/2025 12:33:48

hc-wainwright--co-maintains-buy-on-cardiff-oncology-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Cardi...
08/06/2025 12:06:37

HC Wainwright & Co. analyst Robert Burns maintains Cardiff Oncology (NASDAQ:CRDF) with a Buy and lowers the price target...

why-is-cardiff-oncology-stock-trading-lower-after-colorectal-cancer-data
Why Is Cardiff Oncology Stock Trading Lowe...
07/30/2025 19:27:36

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of PF...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 12:08:36

avis-budget-group-posts-downbeat-earnings-joins-sofi-technologies-seagate-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Avis Budget Group Posts Downbeat Earnings,...
07/30/2025 12:05:06

cardiff-oncology-shares-slide-over-26-in-premarket-trading-after-mixed-q2
Cardiff Oncology Shares Slide Over 26% In ...
07/30/2025 09:47:08

Cardiff Oncology Inc. (NASDAQ: CRDF) plummeted 22.96% in its stock value on Tuesday, following a disappointing second quarter e...

why-lendingclub-shares-are-trading-higher-by-around-23-here-are-20-stocks-moving-premarket
Why LendingClub Shares Are Trading Higher ...
07/30/2025 09:41:46

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 21:06:19

cardiff-oncology-reports-49-orr-with-onvansertib-in-phase-2-mcrc-trial
Cardiff Oncology Reports 49% ORR With Onva...
07/29/2025 20:23:50

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-t...

cardiff-oncology-q2-eps-021-misses-020-estimate-sales-12100k-beat-9286k-estimate
Cardiff Oncology Q2 EPS $(0.21) Misses $(0...
07/29/2025 20:14:38

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(...

cardiff-oncology-announces-data-from-ongoing-randomized-phase-2-first-line-ras-mutated-mcrc-clinical-trial
Cardiff Oncology Announces Data From Ongoi...
07/29/2025 20:12:21

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-t...

ladenburg-thalmann-initiates-coverage-on-cardiff-oncology-with-buy-rating-announces-price-target-of-19
Ladenburg Thalmann Initiates Coverage On C...
07/08/2025 18:44:55

Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Cardiff Oncology (NASDAQ:CRDF) with a Buy rating and announc...

this-makemytrip-analyst-turns-bullish-here-are-top-3-upgrades-for-tuesday
This MakeMyTrip Analyst Turns Bullish; Her...
06/24/2025 13:44:17

this-amylyx-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-4-initiations-for-tuesday
This Amylyx Pharmaceuticals Analyst Begins...
06/24/2025 12:29:58

jefferies-initiates-coverage-on-cardiff-oncology-with-hold-rating-announces-price-target-of-35
Jefferies Initiates Coverage On Cardiff On...
06/24/2025 12:24:00

Jefferies analyst Maury Raycroft initiates coverage on Cardiff Oncology (NASDAQ:CRDF) with a Hold rating and announces Price...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 21:06:23

cardiff-oncology-presents-data-from-investigator-initiated-phase-1b-clinical-trial-evaluating-onvansertib-in-combination-with-paclitaxel-in-patients-with-mtnbc-at-2025-asco-annual-meeting
Cardiff Oncology Presents Data From Invest...
06/02/2025 20:11:00

– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonst...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION